Home » Topics » Regulatory

Regulatory
RSS

Humira approved by FDA for RA

Jan. 3, 2003

No Comments

Foradil Certihaler filed for approval in the U.S.

Jan. 3, 2003

No Comments

Novartis files supplemental NDA for Starlix

Jan. 3, 2003

No Comments

Olux approved for treatment of psoriasis

Jan. 3, 2003

No Comments

Cephalon files sNDA for Provigil

Jan. 3, 2003

No Comments

Casodex 150 mg not recommended for use in U.S. in early prostate cancer

Jan. 2, 2003

No Comments

E.U. approval obtained for once-weekly Actonel/Optinate for postmenopausal osteoporosis

Jan. 2, 2003

No Comments

Once-daily Depakote ER approved for certain forms of epilepsy

Jan. 2, 2003

No Comments

FDA approval for Xalatan as first-line therapy for elevated IOP

Jan. 2, 2003

No Comments

Shire seeks approval of Adderall XR in adults

Dec. 23, 2002

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

Humira approved by FDA for RA

Foradil Certihaler filed for approval in the U.S.

Novartis files supplemental NDA for Starlix

Olux approved for treatment of psoriasis

Cephalon files sNDA for Provigil

Casodex 150 mg not recommended for use in U.S. in early prostate cancer

E.U. approval obtained for once-weekly Actonel/Optinate for postmenopausal osteoporosis

Once-daily Depakote ER approved for certain forms of epilepsy

FDA approval for Xalatan as first-line therapy for elevated IOP

Shire seeks approval of Adderall XR in adults

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Regulatory RSS

Regulatory
RSS